|
Volumn 273, Issue 3, 2007, Pages 689-694
|
DOTA-Tyr3-Octreotate: Labeling with β-emitting radionuclides for the preparation of potential therapeutic radiopharmaceuticals
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETIC ACID;
ANTINEOPLASTIC AGENT;
ASCORBIC ACID;
HOLMIUM;
IODINE 131;
LUTETIUM 177;
OCTREOTATE[3 TYROSINE 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID HO 166];
OCTREOTATE[3 TYROSINE 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID I 131];
OCTREOTATE[3 TYROSINE 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID LU 177];
OCTREOTATE[3 TYROSINE 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID SM 153];
RADIOPHARMACEUTICAL AGENT;
SAMARIUM 153;
SODIUM CHLORIDE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
DRUG DISTRIBUTION;
DRUG STABILITY;
LABELING INDEX;
MALE;
NEUTRON RADIATION;
NONHUMAN;
PANCREAS;
RAT;
ROOM TEMPERATURE;
URINARY EXCRETION;
|
EID: 34547642293
PISSN: 02365731
EISSN: None
Source Type: Journal
DOI: 10.1007/s10967-007-0932-4 Document Type: Article |
Times cited : (5)
|
References (11)
|